Evolution in the management of locally advanced cervical cancer: The experience of Cancer Institute (WIA), Chennai, India

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 4, 2010, Pages 1091-1098

  Shanta, V ^a   Selvaluxmy, G ^a   Swaminathan, R ^a   Shanthi, P ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

Chemo radiation; Disease free survival; Locally advanced cervical cancer; Recurrence; Remote metastasis

Indexed keywords

EID: 78650690497     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cutler SJ, Ederer F. (1958). Maximum utilization of the life table method in analysing survival. J Chronic Dis, 8, 699-712.
2. Ferlay J, Bray F, Pisani P, et al. (2004). GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC cancerbase no. 5, version 2.0. lyon: IARC Press.
3. Green J, Kirwan J, Tierney J, et al. (2005). Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev, 20, CD002225.
4. Heller PB, Maletano JH, Bundy BN, et al. (1990). Clinical-pathologic study of stage IIB, III and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis-a gynecologic oncology group study. Gynecol Oncol, 38, 425-30.
5. Hermanek P, Sobin LH (1987). TNM classification of malignant tumours, fourth fully revised edition. International union against cancer. Heidelberg, Springer-verlag.
6. ICRU Report 38. (1985). Dose and volume specification for reporting intracavitary brachytherapy in gynecology. Bethesda: International commission on radiation units and measurements.
7. Kaplan EL, Meier P. (1958). Non parametric estimation from incomplete observation. J Amer Stat Assoc, 53, 457-81.
8. Krishnamurthi S, Shanta V, Nair NK. (1967). Studies of chemical sensitization in the radiotherapy of oral and cervical carcinoma. Cancer, 20, 822-5.
9. Lanciano RM, Won M, Coia LR, et al. (1991). Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys, 20, 667-6.
10. Lee DW, Kim YT, Kim JH, et al. (2010). Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy. J Gynecol Oncol, 21, 18-23.
11. Mantel N. (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep, 50, 163-70.
12. Morris M, Eifel PJ, Lu J, et al. (1999). Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med, 340, 1137-43.
13. Nag S, Chao C, Erickson B, et al. (2002). The American brachytherapy society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiati Oncol Biol Phys, 52, 33-48.
14. National Cancer Registry Programme. (2008). Two year report of the population based cancer registries 2004-2005. Bangalore: Indian council of medical research.
15. National Cancer Institute. (1999). NCI issues clinical announcement on cervical cancer: Chemotherapy plus radiation improves survival. Bethesda: National cancer institute.
16. Pignon JP, Maitre AL, Maillard E, et al. (2009). Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update in 93 randomised trials and 17,346 patients. Radiotherapy Oncol, 92, 4-14.
17. Rose PG, Bundy BN, Watkins EB, et al. (1999). Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med, 340, 1144-53.
18. Shanta V. (2001). Chemotherapy in gynecologic cancers (Abstract). 16th asia pacific cancer conference. Manila: APCC, 70-1.
19. Shanta V, Swaminathan R, Rama R. (2008). Biennial report 2005-06. Hospital cancer registry. Chennai: Cancer institute (WIA).
20. Vasanthan A, Mrrzumori M, Park JH, et al. (2005). Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys, 61, 145-53.
21. Whitney CW, Sause W, Bundy BN, et al. (1999). Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A gynecologic oncology group and southwest oncology group study. J Clin Oncol, 17, 1339-48.